BioHouston RSS Feed

Advances in Tissue Engineering 2010 18th Annual Short Course on 11-Aug-10 8:30 AM

Wed, 11 Aug 2010 13:30:00 GMT

Advances in Tissue Engineering 2010 18th Annual Short Course
Start Date: 11-Aug-10 8:30 AM
End Time: 14-Aug-10 5:30 PM
Location: Rice University, Houston, Texas
Event Details:

Focusing on advances in the science and technology of tissue engineering and featuring leading scientists from Rice University, the Texas Medical Center, industry, and other institutions.
The course will survey the latest knowledge and technologies in the world of patient-specific therapeutics - from transplantation of cells and tissues to artificial organs.

Visit Their Website for More Information

Rice University

Panasonic Healthcare Day on 18-Aug-10 7:30 AM

Wed, 18 Aug 2010 12:30:00 GMT

Panasonic Healthcare Day
Start Date: 18-Aug-10 7:30 AM
End Time: 18-Aug-10 6:00 PM
Location: Trevisio Restaurant, Houston, TX 77030
Event Details:

PANASONIC HEALTHCARE DAY

Presented with BioHouston

All events at Trevisio’s-Texas Medical Center

7:30 a.m. - 9:00 a.m	BioHouston Breakfast Forum featuring Joe Taylor, CEO Panasonic USA Sponsored by Panasonic USA
9:00 a.m. – 1:30 p.m.	Panasonic Showcase Display
11:30 a.m. – 1:30 p.m.	Complimentary Lunch for Attendees of Panasonic Showcase
5:00 p.m. – 6:00 p.m.	Cocktail Reception for Procurement Departments

You must register for each event separately.

To register for the Breakfast Forum featuring Joe Taylor, Click Here

To register for the Show Case and Complimentary Lunch, Click Here

To register for the Cocktail Reception, Click Here

Trevisio Restaurant

6550 Bertner Ave.

Houston, TX 77030

GCMDM - Summer Social on 25-Aug-10 5:00 PM

Wed, 25 Aug 2010 22:00:00 GMT

GCMDM - Summer Social
Start Date: 25-Aug-10 5:00 PM
End Time: 25-Aug-10 8:00 PM
Location: Guadalajara Mexican Bar & Grill, Houston, TX
Event Details:

Join Houston’s manufacturers as the GCMDM will be hosting a summer social and networking event at the Guadalajara Mexican Restaurant at 9799 Katy Freeway. Guadalajara Mexican Bar and Grill is located between Gessner and Bunker Hill on the South side of the I-10. The GCMDM is a community of manufacturing companies working together to support commercialization of medical device technology in the Gulf Coast region.We hope that you will join the manufacturing community as we take the opportunity to re-connect during our summer break for a simply social event.

Drinks and Hors D' Oeuvres provided

R.S.V.P. Here

Guadalajara Mexican Bar & Grill

9799 Katy Freeway

Houston, TX

CEO Dinner on 26-Aug-10 5:30 PM

Thu, 26 Aug 2010 22:30:00 GMT

This Event is Password Protected;

Associate Advisory Board Meeting on 27-Aug-10 11:30 AM

Fri, 27 Aug 2010 16:30:00 GMT

This Event is Password Protected;

BioHouston's New Series: Strategies for Successful Drug Development on 1-Sep-10 11:30 AM

Wed, 01 Sep 2010 16:30:00 GMT

BioHouston’s New Series: Strategies for Successful Drug Development
Start Date: 1-Sep-10 11:30 AM
End Time: 1-Sep-10 1:00 PM
Event Details:

BioHouston presents a six week Entrepreneurial Series, Featuring Jason Moore:

Go deeper in your understanding of business, regulatory and operational factors for successful drug development

You know the basics; now, deepen your understanding of how to maximize the opportunities and minimize the risks associated with your drug development programs. Learn to integrate your commercial goals with technology, regulatory, and operational realities to get your drug products to market.

Course topics:
•       In-depth review of the drug development process, spanning pre-IND to NDA/BLA and beyond

•       Approach to comprehensively assess new drug candidates, including path-to-market, intellectual property, regulatory, competition and market potential, and inventor/institution

•       See how an opportunity/technology assessment can be used to create a target product profile and integrated development plan

•       Review the most common reasons drug candidates fail and what you can do to mitigate technical, regulatory, operational, and commercial risks

•       Core program management tools you can use to effectively plan and manage product development

•       Regulatory mechanisms that can shorten development times and lower costs (eg, accelerated approval, fast-track and orphan drug designations, special protocol assessments)

•       Learn how you can mine the FDA’s laws, regulations, guidance documents, and training programs – and effectively use consultants and opinion leaders -- to get product development answers and make smart development decisions

•       Understand FDA’s mission and selected FDA initiatives that may drive regulatory decisions affecting your products

•       Determine when and how to effectively interact with the FDA, and how to avoid common pitfalls

More Information to Come!

About the presenter: Jason E. Moore, M.S., M.B.A. is Vice President at PLx Pharma Inc. Jason has nearly 15 years of biotech industry experience, having managed a spectrum of new-drug development, regulatory, medical/technical writing, and successful SBIR/STTR grant programs for both established and emerging biopharma companies. Jason's drug development experience includes both small molecule and biological therapeutics and spans preclinical and CMC related projects, domestic and international clinical trials, and major and minor regulatory submissions. He has used financial modeling and quantitative risk assessment tools for product portfolio management and partnering, and has managed strategic alliance and M&A activities. Among the previous companies for which Jason has worked are Amgen, Antigenics, Aronex Pharmaceuticals, and Introgen Therapeutics. He earned an M.S. in Science and Technology Journalism from Texas A&M University and an M.B.A. from the C. T. Bauer College of Business at the University of Houston. He has been a Visiting Scholar in the Professional Program in Biotechnology at Texas A&M University and been an instructor in the Life Science Entrepreneurship Program at Rice University.

BioHouston Breakfast Forum on 9-Sep-10 7:30 AM

Thu, 09 Sep 2010 12:30:00 GMT

BioHouston Breakfast Forum
Start Date: 9-Sep-10 7:30 AM
End Time: 9-Sep-10 9:00 AM
Location: M. D. Anderson South Campus Research Building II, Houston, TX 77054
Event Details:

Brett P. Giroir, M.D.

Vice Chancellor for Research,

The Texas A&M University System;

Professor, College of Medicine, Texas A&M Health Science Center;
Research Professor, Dwight Look College of Engineering;

Adjunct Professor, The Bush School of Government and Public Service,

TexasA&M University

Dr. Brett P. Giroir is Vice Chancellor for Research for The Texas A&M University System. In his role, Dr. Giroir provides strategic leadership for research and innovation at the System’s eleven universities, seven state agencies, and comprehensive health science center encompassing 27,000 faculty and staff, 110,000 students, a budget >$3 billion, and research expenditures >$670 million annually. Dr. Giroir also leads the System efforts to develop partnerships with external agencies, foundations, academic institutions, and commercial corporations to enhance the System’s mission of research, teaching, service, and economic development for the State of Texas.

Dr. Giroir is a native of Marrero, Louisiana. He received his undergraduate degree in Biology, magna cum laude, from Harvard University and his medical degree from the University of Texas Southwestern Medical Center, Alpha Omega Alpha. His post-doctoral training was conducted at the Howard Hughes Medical Institute in Dallas under the mentorship of Dr. Bruce Beutler. Dr. Giroir remained on the faculty at UT Southwestern from 1993-2004, achieving a rank of tenured Professor. He held two endowed chairs, and served as the Associate Dean for Clinical Affairs at UT Southwestern Medical Center, as well as the first Chief Medical Officer at Children’s Medical Center of Dallas. He has published extensively in both the basic and clinical literature, with special emphasis on host-pathogen interactions and novel therapies for life-threatening infectious diseases. From 2004 until 2008, Dr Giroir accepted the opportunity to serve in the federal government as Deputy Director, then Director, of the Defense Sciences Office of the Defense Advanced Research Projects Agency (DARPA) in Arlington, Va. There, Dr. Giroir directed a research portfolio of approximately $450 million annually that spanned from fundamental physics to human biology. He led the establishment of a comprehensive biology/biomedical program that enabled breakthroughs such as brained-controlled prosthetics and natural approaches to improve immune resistance to infectious diseases. He developed and implemented a portfolio of programs that fundamentally changed the nation’s ability to respond to emerging pathogens and intentional biological attacks. For his DARPA service, Dr. Giroir was awarded the Secretary of Defense Medal for Outstanding Public Service.

Dr. Giroir is currently a member of the federal Threat Reduction Advisory Committee, charged with improving national security against weapons of mass destruction. He also serves as a member of the Scientific and Prevention Advisory Council of the Cancer Prevention and Research Institute of Texas (CPRIT), the Board of Directors for BioHouston, and the Board of the National Space Biomedical Research Institute. He is a former member of the American Board of Pediatrics, the Defense Sciences Research Council, The NASA Planetary Protection Panel, and an alumnus of the Defense Sciences Study Group.

Dr. Giroir is married to Jill S. Giroir since 1985, and has two daughters, Jacqueline and Madeline.

M. D. Anderson South Campus Research Building II

7435 Fannin Street

Houston, TX US 77054

Six Tips on How to Spot a Winning Biotech, From Dendreon Co-Founder Chris Henney

Wed, 14 Oct 2009 19:00:00 GMT

Investing in biotech can be scary. Only one out of 10 new drug candidates ever makes it through the gauntlet of clinical trials to become an FDA approved product, and it usually takes hundreds of millions of dollars and a decade or more of research to separate the winners from the losers. Investors usually can’t bother asking serious questions about profit-and-loss statements, or price-to-earnings ratios, until a company is 15 years old or more. And the hype—from gene therapy, to stem cells, to you fill in the blank—can be quite distracting.

So Christopher Henney, 68, who has seen it all in a 30-year career in biotech as co-founder of Immunex, Icos, and Dendreon, knew he had his work cut out yesterday. He was trying to convince a crowd of 100 financial pros at the CFA Society meeting in Seattle that biotech, the classic boom-or-bust industry, is really a good place to invest.

“I want to de-mythologize the scariness,” Henney said at the outset.

Henney started off his talk by reminding the audience how he and Steve Gillis, a pair of immunologists at the Fred Hutchinson Cancer Research Center, went on to start Seattle-based Immunex, one of the members of what he called “the class of 1983.” These were the second-generation companies, following industry pioneer Genentech, that all went public back in a great wave of enthusiasm for biotechnology. The class included Amgen, Biogen, Cetus, Chiron, Genzyme, and Immunex. Seven of the 10 to 12 biotech companies (Henney didn’t name the losers) that went public in that early wave went on to create market valuations that exceeded $1 billion, Henney said.

But even during that great wave of optimism about the power of new genetic engineering technologies for creating new drugs, there were prominent skeptics. Henney told the story of how he and Gillis had a meeting in the early days of Immunex with “one of the doyennes” of the Seattle investment community, whom he didn’t name. Henney and Gillis told their story with great enthusiasm, and got a rude awakening.

“At the end, I remember him saying, ‘I don’t think it’s a scam, but I won’t introduce you to anybody, either,’” Henney recalled.

Both of them were academic scientists who “had a fair amount of hubris about our self-worth. To be told that what we’re doing was a scam, it wasn’t something I wanted to tell my Mom about,” Henney said.

He added, “It was our welcome-to-the-NFL moment.”

Still, the investor taking that position would have been right for the first 15 years or so. It took 17 years from Immunex’s founding before it struck gold with etanercept (Enbrel), a drug for autoimmune diseases that now generates more than $7 billion a year in worldwide sales for Amgen and Wyeth. It took much longer, and hundreds of millions of dollars more than industry pioneers like Henney thought it would, to create blockbuster drugs like that. “If you had thought about that beforehand, nobody would have given us any money at all,” Henney said.

But they got the money, and learned a lot of lessons along the way. In his talk last week, Henney distilled them into six hallmarks of a successful biotech that investors should look for, along with five red flags to watch out for as well (which I’m going to save for another story).

So, here are the six hallmarks to look for in a successful biotech company, according to Henney:

—Solid Patents. All good biotech companies must have terrific science, and they must have patents to protect it, Henney says. In the industry’s early days, there weren’t many patent attorneys that knew what they were doing, but now there are plenty, he says. An investor ought to ask “how does the science stack up” at a company versus its competitors.

—The science should be focused on an important disease, with potential for breakthroughs. Lots of scientists will argue about what’s important and what’s not, but what an investor needs to know is that a biotech company is at the front of the pack. Immunex focused on an important disease, rheumatoid arthritis, and clearly made a breakthough. “You don’t want to be in fourth or fifth place” with a new drug, he says.

—Great management. This is a must in all industries, but it can’t be overstated in biotech. Interestingly, Henney has noticed some unusual character traits about biotech managers that he says shouldn’t scare off investors. “Like you see in software, these are managers who don’t walk into a room and dominate it. They are often fairly nerdy. But we’re talking about people who are smart, efficient managers,” Henney said.

—Access to capital. A company has to be able to prove it can raise money. Again, and again, and again. “Not many biotech companies go out of business because they lack ideas,” Henney said.

—Luck. “You need it. I’m fortunate to say Lady Luck visited me on many occasions,” Henney said. (I’m not sure how investors are supposed to be able to gauge whether a company has luck on its side, though.)

—Flexible attitudes toward human resources. This might sound nutty to straight-laced business school types, but biotech companies need to give breathing room to some brilliant, creative people who aren’t closely directed by management, Henney said. This can work for a small percentage of the top performers, like some of the brightest people at the National Institutes of Health. The most famous case of this in biotech, which Henney didn’t mention, came from Genentech scientist Napoleone Ferrara, who made discoveries in 1989 on his undirected time that gave birth to the breakthrough cancer drug bevacizumab (Avastin).

“You’ve got to let people follow their curiosity,” Henney said. “For some in the business community, that might sound like a sketchy proposition, but you have to.”

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman

14-Oct-09 2:00 PM

MedSource Honored at Houston Fast 100 Event; Ranked No. 11 on List of Fastest Growing Companies

Mon, 21 Sep 2009 20:00:00 GMT

Houston, September 22, 2009 – Houston’s 100 fastest-growing companies and 2009 Power Five were honored at the Houston Fast 100 luncheon presented by the Houston Business Journal and held at the InterContinental Houston Hotel. MedSource, a Contract Research Organization (CRO) specializing in complex clinical trials, was ranked as No. 11 on the Houston Fast 100 list.

Over 700 Houstonians from the business community cheered on the 2009 Fast 100 award recipients at the luncheon on September 11, 2009, where the rankings were first made public. Companies making the list were ranked by percentage of revenue growth over the past two years. MedSource, with a rapid growth rate of more than 213 percent over the past two years, also earned a place on the 2009 Inc. 5000 List.

“We appreciate recognition from the Houston Business Journal and are proud to be a part of Houston’s thriving business community. There is an active biotech community here in Houston, and it is part of our mission to support the goals of that community. MedSource has been able to find traction in this current economy by focusing on quality, service, and integrity. It is what we have built our reputation on and it is how we will continue to do business,” said Eric Lund, president of MedSource.

In addition to the list of Houston’s 100 fastest-growing companies published in the special Houston Fast 100 section of the Houston Business Journal’s September 11, 2009 issue, top executives of some of the honored businesses shared their insights on what to do and what not to do to succeed.

The Houston Fast 100 event was hosted by the Houston Business Journal and presented by Whitney Bank. Co-sponsors of the event were G&A Partners, Pierpont Communications, Reliant Energy, Staples, and Verizon Wireless.

About MedSource

MedSource is a premier Contract Research Organization (CRO) based in Houston, TX dedicated to delivering on-time, reliable clinical trial management services. MedSource has been providing quality results in Phase I-IV studies since 2001 and has extensive experience in complex clinical trials, with a particular expertise on oncology related programs. They have quickly grown into one of the premier CROs in North America and have been recognized as an Inc. 500/5000 company a Houston Fast 100 company. With clinical trial monitors located throughout North America and active vendor relationships globally, MedSource is able to quickly and effectively meet the clinical trial needs of their clients. More information about MedSource can be found at www.medsource.com or by calling (281) 286-2003.

Company contact:

Chris Kohnhorst
(281) 203-7707
ckohnhorst@medsource.com

21-Sep-09 3:00 PM

BioHouston Newsletter 21-May-09

Sara Mathews — Thu, 21 May 2009 21:00:00 GMT

<img alt="" src="/attachments/wysiwyg/6638/header.jpg" border="0" height="108" width="795">ntitled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Events
News
Jobs

Events

Homeland Security Conference
Day: Wednesday 27-May-09 9:00 AM
Location: InterContinental Hotel, 2222 W. Loop South, Houston, TX 77027
Add to Calendar

CEO Dinner
Day: Thursday 4-Jun-09 5:30 PM
Location: Strip House 1200 McKinney Street Houston, TX 77010
Register Mapquest | Add to Calendar

Breakfast Forum-- Update on State of Texas Bioscience Initiative
Day: Wednesday 10-Jun-09 7:30 AM

Location: M. D. Anderson South Campus Research Building II, 7435 Fannin Street, Houston TX 77054

Rice Alliance for Technology and Entrepreneurship Life Science Technology Venture Forum
Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Associate Advisory Board
Day: Wednesday 17-Jun-09 11:30 AM
Location: BioHouston Offices 2555 Holly Hall St., Ste. 100 Houston, TX 77054
Register Mapquest | Add to Calendar

A Moderated Discussion with Serial Entrepreneur Dale Pfost
Day: Thursday 18-Jun-09 4:00 PM
Location: BioHouston Offices 2555 Holly Hall St., Ste. 100 Houston, TX 77054
Register Mapquest | Add to Calendar

Advances in Tissue Engineering 2009
Day: Wednesday 12-Aug-09 8:30 AM
Location: Duncan Hall at Rice University
Add to Calendar

JAIMA SHOW 2009
Sponsor: JETRO-Houston
Day: Wednesday 2-Sep-09 8:30 AM
Location: Chiba, Japan
Add to Calendar

BioHouston Annual Luncheon
Day: Friday 11-Sep-09 11:00 AM
Location:
Add to Calendar

The Fall 2009 Engineering Career Fair
Day: Thursday 17-Sep-09 9:00 AM
Location: University of Houston Hilton Hotel 4800 Calhoun Rd Houston, TX 77004
Mapquest | Add to Calendar

The UP Experience
Day: Thursday 15-Oct-09 8:30 AM
Location: The Stafford Centre 10505 Cash Road Stafford, TX 77477
Mapquest | Add to Calendar

Texas Life Science Conference
Day: Wednesday 11-Nov-09 to 13-Nov-09
Location: Houston, TX
Add to Calendar

News

VGXI, Inc. Presents at the ASGT 12th Annual Meeting in San Diego, CA May 27-31

VGXI Inc. Presents Issues Related to High Concentration, Multi-Component Plasmid Products at the American Society of Gene Therapy 12th... [More Info]

FDA clears new KCI abdominal wound-care product

Kinetic Concepts Inc. has received Food and Drug Administration approval on its newest product designed to help patients heal from an... [More Info]

Stericycle to buy MedServe for $185 million

Medical waste handling company MedServe Inc. is being acquired by Stericycle Inc. for $185 million in cash. Houston-based MedServe is... [More Info]

MedSource Awarded Services Contract for a Phase III Epilepsy Clinical Trial

(Houston, Texas) – May 12, 2009 - MedSource, a Contract Research Organization (CRO) providing Phase I-IV clinical trials support, announced... [More Info]

Blausen Introduces New 3D Animations iPhone App

Normal 0 false false false st1\:*{behavior:url(#ieooui) } /* Style Definitions */ table.MsoNormalTable... [More Info]

Emerging Biotechnology Clusters

Boston, San Francisco, San Diego, and Cambridge are on everyone’s list of the top biotech clusters. Medicon... [More Info]

KCI claims partial victory in patent fight against Smith & Nephew

Kinetic Concepts Inc. (KCI) said Friday that the Patents Court of the High Court of England and Wales has entered a judgment against Smith... [More Info]

Jobs

Human Factors Design Engineer --new

Company: MEI Technologies, Inc.

This position will be within the Anthropometry and Biomechanics Facility (ABF) that is part of the Space Human Factors Laboratory within... [More Info]

Health Outcomes Research Team Leader

Company: Pharm-Olam International Ltd.

Pharm-Olam International ('POI'), a multi-national Contract Research Organization seeks an experienced Health Outcomes Research Team Leader... [More Info]

Senior Support Specialist

Company: The University of Texas Health Science Center at Houston

POSITION SUMMARY: Performs a variety of advanced and complex tasks to support assigned area. Decisions could impact assigned area. ... [More Info]

Stay up to date with our RSS feeds.

21-May-09 4:00 PM

BioHouston Newsletter 1-May-09

Sara Mathews — Fri, 01 May 2009 15:41:06 GMT

tled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Events
News
Jobs

Events

Marketing your Medical Device products to the E.U.
Day: Thursday 14-May-09 11:30 AM
Location: BioHouston Offices 2555 Holly Hall St., Ste. 100 Houston, TX 77054
Register Mapquest | Add to Calendar

2009 BIO International Conference

If your company is traveling to BIO, please let us know. BioHouston has our own booth in Atlanta, and we'd like you to be a part of it!

Day: Monday 18-May-09 8:30 AM

Location: Atlanta, GA
Add to Calendar

Global Intellectual Property Due Diligence--BIO 2009 Session
Sponsor: Baker & McKenzie
Day: Wednesday 20-May-09 10:00 AM
Location: Georgia World Congress Center (Building B)--B313 Atlanta, GA
Add to Calendar

Healthcare Heroes

Honoring those who serve, innovate and save lives. Do not miss your chance to cheer on the unsung heroes in healthcare. This event is part of Celebrate!Enterprise, a four-day business event.

Day: Wednesday 20-May-09 8:30 AM

Location: Wortham Center, Houston, TX
Add to Calendar

Life Science Technology Venture Forum
Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Rice Alliance for Technology and Entrepreneurship Life Science Technology Venture Forum
Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Advances in Tissue Engineering 2009
Day: Wednesday 12-Aug-09 8:30 AM
Location: Duncan Hall at Rice University
Add to Calendar

JAIMA SHOW 2009
Sponsor: JETRO-Houston
Day: Wednesday 2-Sep-09 8:30 AM
Location: Chiba, Japan
Add to Calendar

The UP Experience
Day: Thursday 15-Oct-09 8:30 AM
Location: The Stafford Centre 10505 Cash Road Stafford, TX 77477
Mapquest | Add to Calendar

Texas Life Science Conference
Day: Wednesday 11-Nov-09 8:30 AM
Location: Houston, TX
Add to Calendar

News

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results

THE WOODLANDS, Texas, April 28 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused... [More Info]

DFB Pharmaceuticals Appoints Maxwell Lea to Vice President Business Development and Corporate Finance

FORT WORTH, Texas, April 23 /PRNewswire/ -- DFB Pharmaceuticals, Inc., has announced the promotion of Maxwell A. Lea, III , to Vice... [More Info]

Federal Research Grants Critical to Aiding Economic Recovery, Advancing Medical Innovation, AdvaMed Witness Tells Panel

WASHINGTON , D.C. – Will Rosellini, President and CEO of MicroTransponder Inc., based in Texas, testified on behalf of the Advanced Medical... [More Info]

Biomed company shuttering San Antonio operation

British orthopedic device firm Smith & Nephew confirmed Monday that it is closing down its 30-employee facility in San Antonio by the end... [More Info]

Vidacare adds oncology nurse to management

Vidacare Corp. has hired a nationally recognized oncology nursing specialist to join the company’s management. Kim Brodie joined the... [More Info]

Opexa gets $1 million in financing

Opexa Therapeutics Inc. has secured about $1 million through a private offering of secured convertible notes and warrants. The cell... [More Info]

Glycos Biotechnologies gets $5 million in funding

Glycos Biotechnologies Inc. has received a $5 million infusion led by venture capital firms Draper Fisher Jurveston and DFJ Mercury. The... [More Info]

Jobs

Senior Support Specialist

Company: The University of Texas Health Science Center at Houston

POSITION SUMMARY: Performs a variety of advanced and complex tasks to support assigned area. Decisions could impact assigned area. ... [More Info]

Formulation Scientist

Company: Vapogenix, Inc.

Vapogenix Inc is a preclinical drug development company located south of the Texas Medical Center in Houston, TX. The Company is seeking... [More Info]

Stay up to date with our RSS feeds.

1-May-09 10:41 AM

BioHouston Newsletter 1-May-09

Sara Mathews — Fri, 01 May 2009 15:28:01 GMT

tled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Events
News
Jobs

Events

If your company is traveling to BIO, please let us know. BioHouston has our own booth in Atlanta, and we'd like you to be a part of it!

Day: Monday 18-May-09 8:30 AM

Honoring those who serve, innovate and save lives. Do not miss your chance to cheer on the unsung heroes in healthcare. This event is part of Celebrate!Enterprise, a four-day business event.

Day: Wednesday 20-May-09 8:30 AM

News

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results

THE WOODLANDS, Texas, April 28 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused... [More Info]

DFB Pharmaceuticals Appoints Maxwell Lea to Vice President Business Development and Corporate Finance

FORT WORTH, Texas, April 23 /PRNewswire/ -- DFB Pharmaceuticals, Inc., has announced the promotion of Maxwell A. Lea, III , to Vice... [More Info]

Federal Research Grants Critical to Aiding Economic Recovery, Advancing Medical Innovation, AdvaMed Witness Tells Panel

WASHINGTON , D.C. – Will Rosellini, President and CEO of MicroTransponder Inc., based in Texas, testified on behalf of the Advanced Medical... [More Info]

Biomed company shuttering San Antonio operation

British orthopedic device firm Smith & Nephew confirmed Monday that it is closing down its 30-employee facility in San Antonio by the end... [More Info]

Vidacare adds oncology nurse to management

Vidacare Corp. has hired a nationally recognized oncology nursing specialist to join the company’s management. Kim Brodie joined the... [More Info]

Opexa gets $1 million in financing

Opexa Therapeutics Inc. has secured about $1 million through a private offering of secured convertible notes and warrants. The cell... [More Info]

Glycos Biotechnologies gets $5 million in funding

Glycos Biotechnologies Inc. has received a $5 million infusion led by venture capital firms Draper Fisher Jurveston and DFJ Mercury. The... [More Info]

Jobs

Senior Support Specialist

Company: The University of Texas Health Science Center at Houston

POSITION SUMMARY: Performs a variety of advanced and complex tasks to support assigned area. Decisions could impact assigned area. ... [More Info]

Formulation Scientist

Company: Vapogenix, Inc.

Vapogenix Inc is a preclinical drug development company located south of the Texas Medical Center in Houston, TX. The Company is seeking... [More Info]

Stay up to date with our RSS feeds.

1-May-09 10:28 AM

BioHouston Newsletter 30-Apr-09

Sara Mathews — Thu, 30 Apr 2009 18:49:30 GMT

Untitled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Events
News
Jobs

Events

2009 BIO International Conference

If your company is traveling to BIO, please let us know. BioHouston has our own booth in Atlanta, and we'd like you to be a part of it!

Day: Monday 18-May-09 8:30 AM

Honoring those who serve, innovate and save lives. Do not miss your chance to cheer on the unsung heroes in healthcare. This event is part of Celebrate!Enterprise, a four-day business event.

Day: Wednesday 20-May-09 8:30 AM

Location: Wortham Center, Houston, TX

Add to Calendar

Rice Alliance for Technology and Entrepreneurship Life Science Technology Venture Forum

Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Advances in Tissue Engineering 2009
Day: Wednesday 12-Aug-09 8:30 AM
Location: Duncan Hall at Rice University
Add to Calendar

JAIMA SHOW 2009
Sponsor: JETRO-Houston
Day: Wednesday 2-Sep-09 8:30 AM
Location: Chiba, Japan
Add to Calendar

The UP Experience
Day: Thursday 15-Oct-09 8:30 AM
Location: The Stafford Centre 10505 Cash Road Stafford, TX 77477
Mapquest | Add to Calendar

Texas Life Science Conference
Day: Wednesday 11-Nov-09 to Friday 13-Nov-09
Location: Houston, TX
Add to Calendar

News

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results

THE WOODLANDS, Texas, April 28 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused... [More Info]

DFB Pharmaceuticals Appoints Maxwell Lea to Vice President Business Development and Corporate Finance

FORT WORTH, Texas, April 23 /PRNewswire/ -- DFB Pharmaceuticals, Inc., has announced the promotion of Maxwell A. Lea, III , to Vice... [More Info]

Federal Research Grants Critical to Aiding Economic Recovery, Advancing Medical Innovation, AdvaMed Witness Tells Panel

WASHINGTON , D.C. – Will Rosellini, President and CEO of MicroTransponder Inc., based in Texas, testified on behalf of the Advanced Medical... [More Info]

Glycos Biotechnologies gets $5 million in funding

Glycos Biotechnologies Inc. has received a $5 million infusion led by venture capital firms Draper Fisher Jurveston and DFJ Mercury. The... [More Info]

Jobs

Senior Support Specialist

Company: The University of Texas Health Science Center at Houston

POSITION SUMMARY: Performs a variety of advanced and complex tasks to support assigned area. Decisions could impact assigned area. ... [More Info]

Formulation Scientist

Company: Vapogenix, Inc.

Vapogenix Inc is a preclinical drug development company located south of the Texas Medical Center in Houston, TX. The Company is seeking... [More Info]

Stay up to date with our RSS feeds.

30-Apr-09 1:49 PM